Dr. Arturo Loaiza-Bonilla, Cancer Treatment Centers of America® (CTCA) Enterprise Research Program Director, discussed recent trials and advances in neuroendocrine cancer research in an interview with Targeted Oncology for World Neuroendocrine Cancer Day.
“There is an increased interest in this disease type that historically was mostly orphaned, or even considered non-malignant, which of course is not the case. While we are still in the process of understanding the results of ongoing clinical trials, the encouraging news is the proliferation of clinical trials related to the neuroendocrine space.”